Search results
Gilead’s Twice-Yearly Shot Prevents HIV. Where the Stock Is Headed.
Barrons.com· 3 days agoThe company said an independent data monitoring committee had stopped the Phase...groups, will now...
Gilead's twice-a-year HIV PrEP drug delivers stunning results in late-stage study - San Francisco...
The Business Journals· 3 days agoInjected only twice a year, an HIV PrEP drug developed by Gilead Sciences Inc. showed zero...
...Higher As Big Tech Stocks Retreat; Nvidia Has Bad Day, But Not As Bad As A Trump Stock (Live...
Investor's Business Daily· 3 days agoShares formed a bullish three-weeks-tight pattern with a 3,242.66 entry and remain in the buy zone...
The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly
Zacks via Yahoo Finance· 3 days agoPfizer and Moderna are grappling with declining sales of their COVID-19 vaccines and drugs. J&J...
Decades before Juneteenth became a holiday, Fort Worth had rich history of celebrations
Fort Worth Star-Telegram via Yahoo News· 2 days agoOne of the earliest Fort Worth Juneteenth celebrations took place in 1882 with “music and dancing,...
Sharon Stone, Charlize Theron, Wilson Cruz Set for THR’s Social Impact Summit
The Hollywood Reporter via Yahoo News· 5 days agoSharon Stone, Charlize Theron, Wilson Cruz and Thomas Sadoski are among the stars who will discuss...
Preparing for Opportunities in a Shifting Market
TheStreet.com· 3 days agoFor a while now, the market has had a consistent pattern: big-cap technology leadership, narrow breadth, and late-day rallies that take the Nasdaq 100...
Daily Brief: Fake Ozempic
Quartz· 3 days agoThe World Health Organization issued a warning about fake Ozempic. There’s just one problem: OpenAI’s ChatGPT, which Apple is putting in its newest...
The Action Has Finally Shifted
TheStreet.com· 3 days agoThe recent pattern of action finally shifted on Thursday. The S&P500, Nasdaq 100 (QQQ) , big-cap technology and Nvidia (NVDA) hit new highs early in the ...
Paying Peter with patent proceeds
Politico· 2 days ago“This should open the door to more competition,” former FDA Commissioner...the U.S. in the fall and winter of 2023. The alert came the same day that Eli Lilly, which makes ...
